EU Challenges China's Medical Device Procurement Practices
The European Commission has found China's public tenders for medical devices to be discriminatory against EU suppliers. Following an investigation, the EU may apply restrictions on Chinese suppliers. Despite ongoing tensions, the EU seeks to negotiate with China to address these procurement imbalances.
The European Commission has determined that EU medical device suppliers face bias in China's public tenders, a conclusion that might prompt restrictions on Chinese suppliers in Europe. The EU executive highlights potential measures such as banning Chinese bidders from EU procurement markets or penalizing their bids for five years.
This investigation, the first under the EU's International Procurement Instrument initiated in April 2024, aims to maintain procurement reciprocity. Evidence indicates that China favors its own devices for hospitals, resulting in low bids unattainable by profit-driven companies.
Despite criticisms from Beijing and escalating tensions, the EU remains open to discussions with China to resolve the issue. Should negotiations fail, the EU could impose corrective measures to exclude Chinese bidders from EU government contracts.
ALSO READ
-
WHO Expands Quality Checks for Contraceptives and AI Tools That Help Spot Tuberculosis
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
-
Human Cost of Faster Work: Chinese Employees Weigh AI’s Promise Against Pay Fears
-
China's August Disasters Yield $5.38 Billion in Losses
Google News